Achondroplasia Natural History Multicenter Clinical Study
NCT02597881 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1500
Last updated 2026-04-01
Summary
The purpose of this study is to create an electronic registry to house phenotypic information from patients with achondroplasia. The initial focus of this registry will be to include U.S. patients with achondroplasia. Once populated, the collective data can be queried to pursue clinical research questions pertaining to health outcomes and treatment options for patients with this conditions. The registry is longitudinal in nature with the functionality to retrospectively enter patients' clinical data from the prenatal period up through the most recent encounter, with all intervening data entered in a chronologic fashion.
Conditions
Sponsors & Collaborators
-
University of Wisconsin, Madison
collaborator OTHER -
Alfred I. duPont Hospital for Children
collaborator OTHER -
University of Texas
collaborator OTHER - collaborator INDUSTRY
-
Greenberg Center for Skeletal Dysplasias
collaborator UNKNOWN - lead OTHER
Principal Investigators
-
Julie Hoover-Fong, MD,PhD · Johns Hopkins University
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-04-30
- Primary Completion
- 2030-12-31
- Completion
- 2030-12-31
Countries
- United States
Study Locations
More Related Trials
-
A Study in Children With Achondroplasia
NCT07301463 ·Status: RECRUITING
-
Registry for Patients With Achondroplasia / Hypochondroplasia (OMPR-Ach/Hy)
NCT05328050 ·Status: RECRUITING
-
Prospective Clinical Assessment Study in Children With Achondroplasia (ACH)
NCT04035811 ·Status: COMPLETED
-
A Phase 2 Study of BMN 111 to Evaluate Safety, Tolerability, and Efficacy in Children With Achondroplasia
NCT02055157 ·Status: COMPLETED ·Phase: PHASE2
-
Multidisciplinary Evaluation and a Genome-wide Analysis in a Cohort of Idiopathic Short Stature Patients
NCT05858606 ·Status: RECRUITING ·Phase: NA
-
A Study of the Genetic Basis of Response to Growth Hormone Treatment in Children With Idiopathic Short Stature
NCT05894876 ·Status: TERMINATED
-
A Clinical Trial to Investigate Long-term Safety, Tolerability, and Efficacy of Weekly Subcutaneous Doses With TransCon CNP in Children and Adolescents With Achondroplasia
NCT05929807 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2/PHASE3
-
A Phase 2 Clinical Trial to Evaluate Efficacy, Safety, and Tolerability of Navepegritide in Combination With Lonapegsomatropin in Children With Achondroplasia
NCT06433557 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Natural History Study of Patients With Excess Androgen
NCT00250159 ·Status: RECRUITING
-
A Study to Learn About Recifercept in Patients With Achondroplasia
NCT05659719 ·Status: COMPLETED
-
Bone Mineral Density (BMD) in Adolescents With Growth Hormone Deficiency (GHD)
NCT00097526 ·Status: COMPLETED
-
C-Type Natriuretic Peptide and Achondroplasia
NCT01541306 ·Status: COMPLETED
-
A Study to Evaluate Long-Term Safety, Tolerability, & Efficacy of BMN 111 in Children With Achondroplasia (ACH)
NCT02724228 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Clinical Trial to Evaluate the Safety and Efficacy of BMN 111 in Infants and Young Children With Achondroplasia
NCT03583697 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of ABSK061 to Assess Safety, Tolerability, Pharmacokinetics, and Efficacy in Children With Achondroplasia
NCT07297875 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Growth Hormone in a Patient With a Dominant-Negative GHR Mutation
NCT05382637 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Growth Hormone Treatment in Patients With Aggrecan (ACAN) Deficiency
NCT03288103 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of SAR442501 in Pediatric Participants With Achondroplasia
NCT06067425 ·Status: TERMINATED ·Phase: PHASE2
-
Effects of Swallowed Steroids on Bone Density and Growth in Pediatric Eosinophilic Esophagitis
NCT03615950 ·Status: WITHDRAWN
-
The Treatment and Natural History of Acromegaly
NCT00001981 ·Status: COMPLETED
-
An Extension Study to Evaluate the Efficacy and Safety of BMN 111 in Children With Achondroplasia
NCT03424018 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Denosumab for Glucocorticoid-treated Children With Rheumatic Disorders
NCT02418273 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Is There a Sensibility Increased in the Growth Hormone at Child With Prader-Willi Syndrome?
NCT01298180 ·Status: COMPLETED ·Phase: PHASE4
-
Diagnosis of Short Stature in Children : Study of a Cohort of Small-sized Consulting Patients
NCT04754516 ·Status: COMPLETED
-
A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Children With Achondroplasia
NCT05353192 ·Status: UNKNOWN ·Phase: PHASE4